Loading...
EMVision Medical Devices Ltd
EMV.AX•ASX
Healthcare
Medical - Devices
A$1.74
A$0.00(0.00%)
EMVision Medical Devices Ltd (EMV.AX) Financial Performance & Income Statement Overview
Explore the financials of EMVision Medical Devices Ltd (EMV.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
60.89%
↑ 60.89%
Operating Income Growth
85.23%
↑ 85.23%
Net Income Growth
29.48%
↑ 29.48%
Operating Cash Flow Growth
-818.30%
↓ 818.30%
Operating Margin
-65.36%
↓ 65.36%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-76.77%
↓ 76.77%
ROE
-36.49%
↓ 36.49%
ROIC
-29.52%
↓ 29.52%
EMVision Medical Devices Ltd (EMV.AX) Income Statement & Financial Overview
Analyze EMVision Medical Devices Ltd’s EMV.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3.49M | $4.57M | $6.65M | $2.03M |
| Cost of Revenue | $0.00 | $0.00 | $202769.00 | $189490.00 |
| Gross Profit | $3.49M | $4.57M | $6.44M | $1.84M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.97 | $0.91 |
| R&D Expenses | $1.82M | $2.84M | $1.85M | $1.22M |
| SG&A Expenses | $4.81M | $3.86M | $4.27M | $3.80M |
| Operating Expenses | $6.62M | $6.71M | $6.13M | $5.03M |
| Total Costs & Expenses | $6.62M | $6.71M | $6.33M | $5.21M |
| Interest Income | $0.00 | $245865.00 | $95343.00 | $89997.00 |
| Interest Expense | $0.00 | $56068.00 | $59651.00 | $16609.00 |
| Depreciation & Amortization | $210917.00 | -$36613.00 | $202769.00 | $189490.00 |
| EBITDA | -$3.14M | -$2.61M | $518668.00 | -$2.91M |
| EBITDA Ratio | -$0.90 | -$0.57 | $0.08 | -$2.48 |
| Operating Income | -$3.14M | -$2.13M | -$6.33M | -$5.21M |
| Operating Income Ratio | -$0.90 | -$0.47 | -$0.95 | -$2.57 |
| Other Income/Expenses (Net) | $60027.00 | -$2.67M | $2.25M | -$326375.00 |
| Income Before Tax | -$3.08M | -$4.80M | -$4.08M | -$3.11M |
| Income Before Tax Ratio | -$0.88 | -$1.05 | -$0.61 | -$1.53 |
| Income Tax Expense | $496078.00 | -$2.18M | -$3.97M | $0.00 |
| Net Income | -$3.57M | -$2.62M | -$112607.00 | -$3.11M |
| Net Income Ratio | -$1.02 | -$0.57 | -$0.02 | -$1.53 |
| EPS | -$0.04 | -$0.03 | -$0.001 | -$0.04 |
| Diluted EPS | -$0.04 | -$0.03 | -$0.001 | -$0.04 |
| Weighted Avg Shares Outstanding | $85.45M | $82.91M | $77.94M | $77.92M |
| Weighted Avg Shares Outstanding (Diluted) | $85.48M | $82.94M | $77.94M | $77.92M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan